Status:
UNKNOWN
Multicenter Randomized Prospective Trial Comparing Methotrexate Alone or in Combination With Adalimumab in Early Arthritis
Lead Sponsor:
Goupe d'Etudes et de Recherche Clinique En Rhumatologie
Conditions:
Rheumatoid Arthritis
Arthritis
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Evaluation of two treatment modalities in early potentially severe early arthritis ( Methotrexate alone or in combination with adalimumab)
Detailed Description
Patients: early ( less than 6 months), active ( DAS\>5.2),potentially severe ( Leiden score\>6) Study design:12 months, prospective , randomized, open Study treatments: Methotrexate at a weekly dose o...
Eligibility Criteria
Inclusion
- Early Active Potentially severe arthritis
Exclusion
- contra indication of methotrexate or anti TNF
Key Trial Info
Start Date :
May 1 2004
Trial Type :
INTERVENTIONAL
End Date :
March 1 2007
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00291915
Start Date
May 1 2004
End Date
March 1 2007
Last Update
February 15 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Cochin
Paris, France, 75014